Map3k8 controls the production of inflammatory, M1, and M2 cytokines in immune cells22–24, 28, 32–34 and has been identified as a potentially interesting target for the treatment of inflammatory diseases, including autoimmune and liver diseases, and diverse types of cancer37–41. This evidence concerns the gene MAP3K8 and liver disorder.